Trials / Withdrawn
WithdrawnNCT00534547
Duodenal Exclusion for the Treatment of Type 2 Diabetes
Phase IV Study of Duodenal Exclusion for the Treatment of Type 2 Diabetes (T2DM)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Medtronic - MITG · Industry
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the role of an experimental surgery that may offer better short and long-term control of T2DM in select patients who have not achieved adequate blood sugar control with regular means.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Duodenal Exclusion | duodenal-jejunal bypass |
Timeline
- First posted
- 2007-09-26
- Last updated
- 2015-07-27
Source: ClinicalTrials.gov record NCT00534547. Inclusion in this directory is not an endorsement.